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Abstract 
 
The prevalence of overweight and obesity among children and adolescents has increased 
considerably over the last few decades.  As a result, increasing numbers of American 
children are developing multiple risk factors for cardiovascular disease, type II diabetes, 
hyperinsulinemia, hypertension, dyslipidemia and hepatic steatosis.   
 
This thesis examines the use of Monte Carlo computer simulation for understanding risk 
factors associated with childhood overweight.  A computer model is presented for 
predicting cardiovascular risk factors among overweight children and adolescents based 
on BMI levels.   
 
The computer model utilizes probabilities from the 1999 Bogalusa Heart Study authored 
by David S. Freedman, William H. Dietz, Sathanur R. Srinivasan and Gerald S. 
Berenson.  The thesis examines strengths, weaknesses and opportunities associated with 
the developed model.  Utilizing this approach, organizations can insert their own 
probabilities and customized algorithms for predicting future events.
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I. Introduction 
 
The prevalence of overweight and obesity among children and adolescents has 
increased considerably over the last few decades.  According the American Medical 
Association, the prevalence of overweight tripled in children and adolescents aged 6 – 19 
years between 1980 and 2002 (Ogden, Carroll, Curtin, et al. 2006, p1549).  As this trend 
continues, increasing numbers of American children are developing multiple risk factors 
for cardiovascular disease, type II diabetes, hyperinsulinemia, hypertension, dyslipidemia 
and hepatic steatosis.  For the majority, health-related consequences begin in childhood 
and continue well into adulthood.   
In response to this problem, organizations across America are banding together in 
the fight against childhood overweight.  These partnerships focus on a variety of issues 
ranging from behavior to nutrition to physical activity.  However, limited resources 
require organizations to carefully select only the most effective and efficient 
interventions.  These decisions require thorough evaluation of national trends, scientific 
evidence and long-term strategies.   
Organizations seeking to identify successful strategies require access to a wide 
variety of effective decision-making tools.  The purpose of this thesis is to examine the 
use of Monte Carlo computer simulation as a tool for assisting organizations in 
identifying effective strategies for fighting childhood overweight.  Utilizing this 
approach, organizations can insert their own probabilities and customized algorithms for 
predicting future events. 
II. Background 
 
The problem of overweight and obesity in the U.S. is not just a personal issue but 
rather a problem that impacts the quality of life, economic performance and 
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physical/mental status of whole populations.  For example, consider the implications of 
overweight on the U.S. economy.  Significant attention is given to the rising cost of 
health care.  Health expenditures as a percentage of GDP in the United States have 
increased from less then three percent in the 1970’s to approximately 16 percent in 2004 
(see Figure II-1).  The United States spends more on health care, in terms of per capita 
health spending, than any other nation members of the Organization for Economic 
Cooperation and Development (OECD).  Considerations for many factors including 
quality, capacity and innovation are required before making judgments regarding the 
positive and/or negative implications of these spending trends.  However, it is not 
disputed that health care expenditures are significant and growing.   
Figure II-1 Total national health expenditures and as a percentage of GDP 
 
 
Source: Custer, William S. (January, 2006). HA8250: Health Economics and Financing. Class Lecture 
1 Georgia State University 
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Researchers project that health spending will increase to $3.4 trillion, or almost 
20% of the GDP by 2013 (Hefler, Smith, Keehan, et al. 2004, p82).  To undertake any 
serious attempt at controlling cost, policymakers must seek to more fully integrate public 
health into the U.S. health care system.  It is usually cheaper to prevent illness, than to 
treat illness. 
Chronic disease 
 
In an effort to effectively control health care cost, the U.S. must focus on the 
problem of chronic disease.  Chronic conditions are defined as illnesses or impairments 
that last a year or longer.  According to the CDC’s National Center for Chronic Disease 
Prevention and Health Promotion, more than 90 million Americans live with chronic 
illnesses and chronic diseases account for more than 75% of the nation’s $1.4 trillion of 
medical care costs (National Center for Chronic Disease Prevention and Health 
Promotion, 2005, p3).   
Chronic diseases, such as cardiovascular disease (primarily heart disease and 
stroke), cancer, and diabetes, are among the most prevalent, costly, and preventable of all 
health problems (National Center for Chronic Disease Prevention and Health Promotion, 
2005, p2). 
Overweight – A major contributor to chronic disease 
 
Research shows that “the risk of developing diabetes, gallstones, hypertension, 
heart disease and stroke increases with severity of overweight among both women and 
men” (Field, Coakley, Must, et al. 2001, p1581).   
According to Calle and Walker-Thurmond, “In both men and women, body-mass 
index was significantly associated with higher rates of death due to cancer of the 
esophagus, colon and rectum, liver, gallbladder, pancreas, and kidney; the same was true 
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for death due to non-Hodgkin’s lymphoma and multiple myeloma.  Significant trends of 
increasing risk with higher body-mass-index values were observed for death from cancers 
of the stomach and prostate in men and for death from cancers of the breast, uterus, 
cervix, and ovary in women” (Calle, Rodriguez, Walker-Thurmond, et al. 2003, p1625). 
As the number of overweight children and adolescents in the U.S. increases so 
will the number of overweight adults.  Figure II-2 shows the probability of overweight at 
age 35 predicted from childhood BMI at the 95th percentile.  According to Guo and 
Chumlea “Body mass index values at or above the 75 percentile are associated with 
increased morbidity and mortality in adulthood, and there are significant correlations 
between BMI values in childhood and in adulthood (Guo and Chumlea 1999, p145) 
 
Figure II-2 Probability of overweight at age 35 predicted from childhood BMI at the 95th percentile 
 
 
Source: Guo, S.S., Chumlea, W.C. (1999) Tracking of body mass index in children in relation to 
overweight in adulthood.  The American Journal of Clinical Nutrition, 145, 145-147. 
 
Health related consequences of child and adolescent overweight 
 
The problem of overweight in children and adolescent is associated with several 
health-related consequences.  The negative impact of these consequences may be 
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experienced in childhood and/or be experienced later on in adulthood.  Overweight 
children and adolescents are at an increased risk for:  
Cardiovascular Disease – Risk factors include abnormal cholesterol levels, hypertention, 
elevated triglycerides and glucose intolerance.  Studies have shown “an evolving 
epidemic of cardiovascular risk in youth, as evidence by an increase in the prevalence of 
overweight’ (Sorof, Lai, Turner, et al. 2004, p475). 
 
Psychosocial Risks and Discrimination – Overweight children are often targets of early 
social discrimination.  Social stigmatization and negative stereotyping can cause 
psychological stress and low self-esteem which, in turn, can hinder academic and social 
functioning that persists well into adulthood (CDC, 2007).  Other social and emotional 
health consequences include social marginalization, teasing/bullying, depression and 
negative body image (Institute of Medicine, 2004, p2). 
 
Glucose Intolerance – a pre-diabetic state, that is associated with insulin resistance and 
increased risk of cardiovascular pathology (Institute of Medicine, 2004, p2). 
 
Diabetes Mellitus Type II / Insulin Resistance – What was once considered primarily an 
adult disease, type 2 diabetes has increased dramatically in children and adolescents. 
Overweight and obesity are closely associated with type 2 diabetes (Pi-Sunyer, 2002, 
p23S).  
 
Hyperinsulinemia – A condition where excess levels of circulating insulin are in the 
blood.  It is not diabetes, but it is often associated with metabolic syndrome and type 2 
Diabetes (Pi-Sunyer, 2002, p22S).   
 
Dyslipidemia – Overweight is associated with disruptions in the amount of lipids in the 
blood (Institute of Medicine, 2004, p2). 
 
Hepatic Steatosis (a.k.a. fatty liver) –A reversible condition where large vacuoles of lipid 
accumulate in hepatocytes (the cells of the liver).  Hepatic Steatosis is a health condition 
associated with increased weight (CDC, 2007, p1). 
 
Other associated health conditions include orthopedic problems (Institute of 
Medicine, 2004), sleep apnea (CDC, 2007), gallstones (Institute of Medicine, 2004), 
asthma (Gennuso, Epstein, Paluch, et al. 1998), reproductive complications (Cnattingius, 
Bergstrom, Lipworth, et al. 1998) and menstrual abnormalities (Institute of Medicine, 
2004). 
Given the correlation between overweight children and overweight adults, health 
conditions associated with childhood overweight expand to include cancer and arthritis.  
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Fourteen percent of cancer deaths among men and 20% of cancer deaths among women 
may be due to overweight and obesity (Calle, Rodriguez, Walker-Thurmond, et al. 2003).  
Arthritis is the leading cause of disability in the United States.  According to the U.S. 
Department of Health and Human Services (2007), the risk of developing arthritis 
increases by 9-13% for every two-pound increase in weight. 
Interventions for overweight (and its corresponding chronic diseases) will require 
multifaceted approaches that seek to reverse years of cultural, behavioral and social 
norms.  Interventions must address root cause, begin early in life to establish lifelong 
pattern of behavior and utilize effective methodologies for tracking progress.   
Tracking overweight: National Health and Nutrition Examination Surveys 
(NHANES) 
 
Two primary tools for tracking overweight in children and adolescents include the 
National Health and Nutrition Examination Survey (NHANES) and the Centers for 
Disease Control and Prevention growth charts.   
In 1956, Congress passed the National Health Survey Act providing 
legislative authority for a recurring survey to provide statistical data on the amount, 
distribution, and effects of illness and disability in the United States.  Three sources 
of data collection fulfilled this purpose. 
• Direct interviews with survey participants 
• Clinical tests, measurements and physical examinations 
• Information retrieved from hospitals, clinics and doctors offices 
 
In compliance with the National Health Survey Act, three initial surveys were 
performed. 
1. 1960-62—National Health Examination Survey I (NHES I) – Focused on 
selected chronic disease of adults aged 18-79; 
2. 1963-65—National Health Examination Survey II (NHES II) - Focused on the 
growth and development of children aged 6-11; and 
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3. 1966-70—National Health Examination Survey III (NHES III) - Focused on 
the growth and development of children aged 12-17 
 
In 1970, the Secretary of the Department of Health directed that additional 
emphasis be placed on nutrition.  As a result, the National Nutrition Surveillance System 
was implemented.  The purpose of the system was to measure and track the nutritional 
status of the U.S. population.   
Data from both systems were combined in the 1970’s to form the National Health 
and Nutrition Examination Surveys (NHANES).  Four surveys were conducted between 
1970 and 1994. 
• 1971-75—National Health and Nutrition Examination Survey I (NHANES I) 
• 1976-80—National Health and Nutrition Examination Survey II (NHANES 
II) 
• 1982-84—Hispanic Health and Nutrition Examination Survey (NHANES) 
• 1988-94—National Health and Nutrition Examination Survey III (NHANES 
III) 
 
Since 1999, the NHANES survey has been performed annually.  Each year, 
approximately 7,000 randomly selected residents across the United States have the 
opportunity to participate (NCHS, 2007).  Today, the survey is a valuable tool in 
providing objective assessment data of health status and overweight for individuals living 
in the United States.  
Tracking overweight: Centers for Disease Control growth charts 
 
In 1977, the National Center for Health Statistics (NCHS) developed a series of 
growth charts for the purpose of assessing the development of children and youth.  The 
growth charts were developed utilizing data from the Fels Research Institute.  Data 
consolidated empirical data of youth between the years 1929 and 1975.  In 1978, the 
Centers of Disease Control and Prevention created a normalized version of the NCHS 
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percentiles to serve as an easy reference for pediatricians (Dibley, Goldsby, Staehling, et 
al. 1987, p736).   
The 1977 NCHS growth charts gained national and international recognition as a 
standard for assessing the health status of infants and youth.  The charts served as a 
cornerstone in research and are referenced in numerous studies evaluating prevalence, 
trends, population comparisons and interventions.  At the international level, the World 
Health Organization (WHO) adopted the 1977 charts as standard reference (World Health 
Organization, 1978). 
As the charts gained in popularity, they also underwent scrutiny.  The primary 
issues centered on the validity of the Fels data.  Inconsistencies include mismatches 
between NCHS percentiles and 1978 versions of normalized data, methodologies used for 
adjusting adolescent data versus younger children, over-representation of formula fed 
infants and non-representative datasets. At the time, these data were the best available 
and limitations were clearly stated in the initial release. 
To address these issues the Centers for Disease Control and Prevention released a 
series of updated growth charts in May of 2000 (see Appendix A).  Today, these same 
growth charts are the recommended standard for assessing children in the United States.  
The measurement data for creating the revised growth charts were obtained from a series 
of sources including:  
• National Health Examination Survey (NHES), Cycles II and III 
• National Health and Nutrition Examination Survey (NHANES) I, II, and III 
• U.S. Vital Statistics 
• Wisconsin Vital Statistics 
• Missouri Vital Statistics 
• Fels Longitudinal Study 
• Pediatric Nutrition Surveillance System 
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Survey-specific sample weights were applied to the national survey sample data 
to assure representation of the U.S. population according to age, gender, and racial/ethnic 
composition at the time the surveys were conducted (CDC, 2007). 
Defining overweight in children and adolescents 
 
Several methodologies exist for measuring overweight in children and 
adolescents.  Methodologies include body mass index, skin fold thickness measurements 
utilizing calipers, underwater weighing, bioelectrical impedance, dual-energy x-ray 
absorptiometry (DXA) and computerized tomography.  However, tracking overweight at 
the national level requires adoption and agreement towards a national standard.  In 
identifying this standard, issues of quality, ease of use (i.e., required training and 
equipment) and cost come into consideration.  Based on these factors, the CDC 
recommends use of body mass index (BMI) for population studies (CDC, 2006). 
Quetelet index 
 
The quetelet index (or body mass index) was invented between 1830 and 1850 by 
social scientist Adolphe Quetelet.  The index is a statistical measure of the weight of a 
person scaled according to height.  As the measurement gained popularity during the 
1980’s, the term was more commonly referred to as “body mass index”.  Both terms are 
used interchangeably throughout this thesis to prevent confusion between referenced 
studies and data sources.  
BMI is one of the best measurements for measuring overweight and obesity in 
populations.  Only height and weight are required, making BMI screening easy and 
inexpensive.  BMI is calculated the same way for both adults and children.  According to 
the CDC (2006), calculations for BMI are as follows: 
Equation 1 BMI in kilograms and meters 
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Kilograms and meters (or centimeters) = weight (kg) / [height (m)] 2 
 
Equation 2 BMI in pounds and inches 
 
Pounds and inches = weight (lb) / [height (in)] 2 x 703 
 
Although BMI is the recommended standard for population studies, it is not 
without its limitations.  According to the CDC (2006), BMI correlation to body fatness 
“varies by sex, race, and age”.  Examples of variance related to BMI include: 
• At the same BMI, women tend to have more body fat than men do.  
• At the same BMI, older people, on average, tend to have more body fat than 
younger adults do.  
• Highly trained athletes may have a high BMI because of increased 
muscularity rather than increased body fatness. 
 
Interpretations for BMI vary substantially between adult and children. 
According to the CDC (2006), weight status for adults is classified as follows: 
Table 1 Adult BMI weight status 
 
BMI Weight Status 
Below 18.5 Underweight 
18.5 – 24.9 Normal 
25.0 – 29.9 Overweight 
30.0 and Above Obese 
 
Source: Centers for Disease Control and Prevention (August 26, 2006). About BMI for Children and 
Teens. Retrieved March 10, 2007 from 
http://www.cdc.gov/nccdphp/dnpa/bmi/childrens_BMI/about_childrens_BMI.htm 
 
The criteria for establishing weight status in children is slightly more complex.  
This is due to significant differences in amount of body fat between boys and girls as well 
as for specific age groups.  According to the CDC (2006), child and adolescent weight 
status is classified as follows: 
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Table 2 Child and adolescent weight status 
 
Weight Status 
Category Percentile Range 
Underweight Less than the 5th percentile 
Normal 5th percentile to less than the 85th percentile 
Overweight 85th to less than the 95th percentile 
Obese Equal to or greater than the 95th percentile 
 
Source: Centers for Disease Control and Prevention (August 26, 2006). About BMI for Children and 
Teens. Retrieved March 10, 2007 from 
http://www.cdc.gov/nccdphp/dnpa/bmi/childrens_BMI/about_childrens_BMI.htm 
 
Percentile range is defined using the May 2000 growth charts (see Appendix A) 
based on a combination of data sources.    
Trends in tracking overweight among U.S. children and adolescents  
 
Utilizing the percentile ranges defined in Table 2, the prevalence of overweight 
and obesity among U.S. children and adolescents has increased considerably over the last 
few decades.   
The Institute of Medicine (2004) found that: 
 “Over the past three decades, the childhood obesity rate has more than 
doubled for preschool children aged 2-5 years and adolescents aged 12-19 years, and 
it has more than tripled for children aged 6-11 years. At present, approximately nine 
million children over 6 years of age are considered obese.” (IOM, 2004, p1) 
 
For detailed prevalence data for children and adolescents who are “at risk of 
overweight” and/or “overweight” by sex, age, and racial/ethnic group (see Appendix B & 
C). 
III. Literature review 
 
The tools of modeling, analysis and simulation are widely used to assess systems 
that evolve dynamically and/or have behaviors that are uncertain.  Nelson (1995) found 
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computerized simulation modeling to be a valuable asset in the following industries and 
applications. 
Manufacturing – capacity planning, inventory control and evaluation of process 
quality 
 
Health-care – hospital staffing and medical decision making 
 
Computer applications – designing hardware configurations and operating-system 
protocols 
Communication - evaluating network reliability 
 
Economic – portfolio management and forecasting  
 
Business – consumer behavior, product distribution and logistics 
 
Biological – population genetics and epidemiology 
The purpose of this thesis is to achieve the following: 
Research Objective:  This thesis examines the use of Monte Carlo computer 
simulation for understanding cardiovascular risk factors associated with childhood 
overweight.  A computer model is presented for predicting cardiovascular risk 
factors among overweight children and adolescents based on BMI percentiles.   
 
The primary benefits of computer modeling include:  
Explaining relationships / sensitivity - For example, how do increases in childhood 
overweight affect increases in risk factors for elevated triglycerides? 
 
Predicting future events – As an example, if current trends in childhood BMI continue, 
what is the expected number of children at risk due to high blood pressure in five years? 
 
Examining “what if” scenarios - In other words, if one variable is modified – what 
changes are expected in other variables within the system?  For example, if the rate in 
number of children who are “overweight” is reduced by half – What is the expected 
number of children with elevated total cholesterol?   
   
Monte Carlo modeling 
 
A Monte Carlo simulation is a statistical method involving computer simulation 
in which data is generated randomly, enabling assessment of the probabilities of certain 
known outcomes.  For this study, a random number generator is used to replicate both 
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weight status and the occurrence of specific cardiovascular risk factors in children and 
adolescents.   
Monte Carlo simulation is utilized in several studies for predicting future events 
and outcomes in the field of public health.  For example, Bray (2002) utilized Markov 
Chain Monte Carlo (MCMC) simulation to address a 5-year delay in the publishing of 
cancer incidence and mortality rates.  Bray noted that current health models are rarely 
utilized because of oversimplistic methodologies and/or models that are dependent on 
questionable parametric assumptions. Bray proposes a new model based on MCMC 
simulation and utilization of Bayesian statistics. 
Stuart and colleagues (2003) utilized Monte Carlo experiments to simulate data 
loss in testing the robustness of proportion-based quality indicators for asthma.  Through 
the use of Monte Carlo modeling, asthma quality indicators measures were determined 
highly robust to systematic and random data loss. 
Chen, Yen and Tung (2001) modeled the disease natural history of Type 2 
diabetes mellitus using Monte Carlo Markov processes.  The goal of the study was to 
determine the cost effectiveness of mass screening in Taiwan.  Two separate screening 
regimes were compared with a control group.  Direct costs and utilities were incorporated 
to calculate the incremental costs per life-years gained and per quality-adjusted life-years 
for biennial and five-yearly screening regimes.  Through the use of Monte Carlo 
modeling, the study showed 5-year interval mass-screening for Type 2 diabetes mellitus 
to be cost-effective in Taiwan. 
Overview of the Bogalusa Heart Study 
 
The computer model utilizes probabilities from the 1999 Bogalusa Heart Study 
published by Freedman, Dietz, Srinivasan and Berenson (The relation of overweight to 
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cardiovascular risk factors among children and adolescents: The Bogalusa Heart Study. 
Pediatrics, 103, 1175–1182).  The objective of the Bogalusa Heart Study was to utilize 
quetelet index cut points to examine the relation of overweight to adverse risk factors 
levels.  Table 3 shows the relationships between Quetelet index and adverse 
cardiovascular risk factors by age group. 
Table 3 Relation of quetelet index to adverse risk factors, by age group 
 
Quetelet Index Percentiles 
Ages 5-10 years <25 25-49 50-74 75-84 85-94 95-97 >97 
Sample Size 904 817 798 340 384 100 256 
Total Cholesterol > 200 mg/dL 9 10 10 13 18 17 23 
Triglycerides > 130 mg/dL 2 3 3 6 10 10 21 
Low-Density Lipoprotein Cholesterol > 130 mg/dL 8 8 9 10 18 12 23 
High-Density Lipoprotein Cholesterol < 35 mg/dL 5 5 6 4 8 7 18 
Fasting Insulin > 95th Percentile 2% 2% 3% 3% 4% 10% 27% 
Systolic Blood Pressure > 95th Percentile 2% 2% 4% 6% 7% 12% 22% 
Diastolic Blood Pressure > 95th Percentile 2% 2% 4% 9% 7% 9% 14% 
                
Ages 5-10 years <25 25-49 50-74 75-84 85-94 95-97 >97 
Sample Size 1189 1122 1249 611 763 210 424 
Total Cholesterol > 200 mg/dL 6 6 7 9 15 12 19 
Triglycerides > 130 mg/dL 3 4 5 7 12 18 32 
Low-Density Lipoprotein Cholesterol > 130 mg/dL 4 4 6 9 13 12 21 
High-Density Lipoprotein Cholesterol < 35 mg/dL 6 9 10 12 14 16 21 
Fasting Insulin > 95th Percentile 1% 1% 3% 2% 5% 10% 25% 
Systolic Blood Pressure > 95th Percentile 2% 4% 6% 4% 7% 5% 11% 
Diastolic Blood Pressure > 95th Percentile 4% 5% 5% 5% 4% 4% 9% 
 
Source: Freedman. D.S., Dietz W.H., Srinivasan. S.R., Berenson. G.S., (1999) The relation of 
overweight to cardiovascular risk factors among children and adolescents: The Bogalusa Heart Study. 
Pediatrics, 103, 1175–1182. 
 
The Bogalusa (Louisiana) Heart Study included seven cross-sectional 
examinations, each with a participation rate of >80% between 1973 and 1994.  The study 
population was 43,000 (1/3 black, 2/3 white) schoolchildren between the ages of 5 and 17 
years.  Analysis was restricted to individuals who properly fasted and who had recorded 
values for weight, height, total cholesterol and systolic blood pressure.  The resulting 
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sample included 9,167 schoolchildren between the ages of 5 and 17 years (Freedman, 
Dietz, Srinivasan, et al. 1999, p1175). 
The Bogalusa study provides valuable insight into cardiovascular risk factors 
among children and adolescents.  Additionally, the study provides the opportunity for 
building a simulation that otherwise would not be possible.  However, the study itself 
provides only static information - a snapshot in time.  It provides great insight into the 
prevalence and even incidence of cardiovascular risk factors among children and 
adolescents but does not provide any prediction in how risk factors change in relation to 
time and/or weight status. 
Simulation, on the other hand, is dynamic.  Each iteration of a simulation yields 
different results.  Much like real life, conditions change from day to day.  For example, 
suppose one’s weight is measured once per week.  In the first week, one weighed 175.12 
lbs.  In the second week, the probability that one would again weigh 175.12 lbs is highly 
improbable.  One’s weight today is much more likely to fall somewhere above or below 
175.12 lbs.   
Weight fluctuation may be due to a variety of variables.  Some are attributed to 
what is called “natural variance”: e.g., at the time of weight measurement an individual 
had not eaten breakfast, had lost water from a morning jog, etc.   Some changes in weight 
are considered “significant”: e.g., eating or exercised habits had changed, the individual 
had caught a virus, or became pregnant.  Simulation seeks to explain both natural and 
significant variance through probability theory.   
Additionally, simulation becomes helpful when stringing together multiple 
probability distributions.  When the number of variables is small, then the calculations 
are easily performed.  For example, consider the normal probability distribution in Figure 
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III-1.  The y-axis represents the probability that a randomly selected individual’s average 
daily duration of moderate exercise equals the corresponding duration in minutes (x-
axis).  The ability to compare probabilities for increased vs. decreased exercise is 
relatively easy.   
Figure III-1 Example probability distribution 
 
 
Now consider a slightly more complex model in Figure III-2.   Assume, again that 
distribution A is a probability distribution for average level of exercise.  If the 
individual’s daily exercise level is significant enough to fall within the dark purple 
region, then the probability of getting a particular disease outcome is determined by 
distribution B.  Otherwise, the probability of getting the particular disease is determined 
by distribution C.  The final “Predicted Prevalence” is calculated using a combination of 
outputs from distributions B and C.   
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Figure III-2 Example of a chain of probability distributions 
 
Figure 3-2 provides a good example of the complexity that derives from 
syndemics.  “Syndemics” is a term invented to describe a set of linked health problems 
and is defined as two or more afflictions, interacting synergistically, contributing to 
excess burden of a disease in a population (CDC, January 2005).  For a more in-depth 
explanation on modeling, see Computer Simulation Theoretical Example in Appendix D. 
Through simulation, researchers can tweak probabilities to better understand the 
impact of certain system events.  Simulation may help to answer questions such as: 
How do reductions in BMI impact cholesterol levels?   
What if interventions target the reduction of BMI for a particular sex and/or 
ethnicity group?   
What if current trends in BMI continue for 5 years?   
What if the trends in BMI stay the same but the risk of hypertension increases?   
 
Simulation has proven helpful in addressing these and many more question of this type.   
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Simulation and Probability Theory 
 
Two important laws are critical to the performance of a Monte Carlo simulation.  
They are the Law of Large Numbers and Bayes’ Law.  The Law of Large Numbers is a 
fundamental concept in probability.  According to the law: 
If an event of probability p is observed repeatedly during independent 
repetitions, the ratio of the observed frequency of that event to the total number of 
repetitions converges towards p as the number of repetitions becomes arbitrarily 
large.  
 
In other words, as an experiment is repeated over and over, the observed probability 
approaches the actual probability distribution.   
The second law critical to simulation is Bayes Law.  Before delving into this law, 
it is important to understand the two primary schools of thought for assigning 
probabilities to various applications: Frequentist and Bayesian interpretations. 
Frequentists assign probabilities to random events based on subsets of a 
population as proportions of the whole (Durrett, 1994).  For example, in the Bogalusa 
Heart Study 432 children ages 5 to 10 years of age are at risk for total cholesterol levels 
greater than 200 milligrams/deciliter (md/dL).  The total sample size of children ages 5 to 
10 screened for total cholesterol is 5,568.  Based on these findings the proportion of 
children ages 5 to 10 with total cholesterol levels greater than 200 md/dL is 12%.  In 
other words, using a frequentest view, the probability of a child ages 5 to 10 having a 
total cholesterol level greater than 200 md/dL is 0.12. 
Bayesian interpretations (or Bayes' Law) is valid for both interpretations of 
probability.  Bayes' Law relates a condition on the probability distribution (Durrett, 
1994).  In other words, probabilities are updated in light of new evidence.  Using the 
example above, a randomly selected 5 to 10 year old has a 0.12 probability of having a 
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total cholesterol level exceeding 200 md/dL.  If the 5 to 10 year old child, selected at 
random, is known to be overweight (i.e., the child has a quetelet index greater than 95%).  
This additional information may be used to update the original probability.  In light of the 
additional information regarding the child's weight status, the child now has 0.17 
probability of having a total cholesterol level exceeding 200 md/dL. 
The simulation model in this study utilizes quetelet index as a conditional 
attribute for each randomly generated event.  Probabilities for predicting adverse 
cardiovascular risk factors are calculated utilizing the principles of Bayes Law.   
IV. Model Development 
 
Utilizing a similar methodology as was described earlier, the cardiovascular risk 
factor model simulates trails based on single individuals.  Each individual is first assigned 
a weight status using a quetelet index.  Second, the individual is assessed against a series 
of probabilities (thresholds) to determine their susceptibility to various cardiovascular 
risk factors.  Each probability is determined given the individuals assigned weight status 
(i.e., quetelet index).   
The term “event” in probability refers to an unknown future result, while the term 
“system event” refers to a change in the status of a system (Nelson, 1995, p25).  A system 
event is synonymous with implementation of an intervention.  For example, a single 
event may represent a 5 to 10 year old who is assigned a quetelet index in the 88th 
percentile.  By definition, this individual is considered “at risk of overweight”.  The same 
child is then assessed for total cholesterol.  If this child’s total cholesterol level is greater 
than 200 mg/dL, they are considered at risk for cardiovascular disease based on total 
cholesterol.  A 5-10 year old child with a quetelet index equal to the 85th percentile has a 
probability of 0.157 for exceeding the 200 mg/dL threshold.  Generating a random 
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number between zero and one using a uniform distribution provides the random number 
0.235.  Because 0.235 is greater than 0.157, this individual in not considered “at risk” for 
total cholesterol even though the child is “at risk of overweight”.  The same is repeated 
for multiple risk factors and for multiple trials until the Law of Large Numbers is 
achieved. 
Two separate models are assessed.  The first will model cardiovascular risk 
factors among children ages 5 to 10 years.  The second will model cardiovascular risk 
factors among adolescents ages 11 to 17 years.  These age groups are consistent with the 
age groups established in the Bogalusa Heart Study.  Age group categories allow for 
more accurate predictions of individual quetelet index, risk factor susceptibility as well as 
changes in height and weight metrics due to puberty. 
@RISK Version 4.5.3 
 
The simulation utilizes @RISK version 4.5.3 (student version) released February 
of 2003.  The tool is a proprietary product owned by the Palisade Decision Tools 
Corporation.   @RISK 4.5 is a Monte Carlo simulation add-in for Microsoft Excel 
version 97 (8.0) or higher. 
Model assumptions 
 
As stated in the introduction, the purpose of this thesis is to examine the use of 
Monte Carlo computer simulation for understanding risk factors associated with 
childhood overweight.  As such, it is hoped that future research will build and ultimately 
improve upon the presented concepts.  Even the most robust and extensively developed 
models contain uncertainties and error.  All simulation models have the potential for 
improvement.  That said, simulation is built on probability theory and mathematics.  
Computer modeling is a statistically viable tool for modeling real-life situations and for 
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studying how stochastic systems work.  “Stochastic” is a term meaning to have a random 
variable.  A stochastic model is a tool for estimating potential outcomes by allowing for 
random variation.  The more accurate the model, the better the model is in predicting 
outcomes.   
In accordance with the scope and purpose of this thesis, the following 
assumptions apply:     
• The model is subject to limitations in population sample sizes, sampling error and 
aggregation of data for ages 5-10 years and 11-17 years. 
• The model collapses probabilities from Freedman et. al. into specific risk factor 
categories and does not account for the complexities of relationships that exist 
between risk factors.  The purpose of this model is to illustrate the benefits in 
simulating cardiovascular risk factors among overweight children and adolescents 
and does not seek to explain all relationships that may exist between data points.   
• The model is limited by the generalizations of calculating trend lines and in using 
quetelet index ranges for each predicted cardiovascular risk factor. 
• The Monte Carlo simulation is performed for five iterations of 1,000 trials.  
Therefore, each simulation is limited to a total of 5,000 trials.    This number of 
trials is assumed sufficient in achieving the Law of Large Numbers.  Additionally, 
each iteration utilizes a different algorithm for generating numbers and therefore 
achieves greater randomness. 
 
Model inputs 
 
Thompson, Burmaster and Crouch are pioneers in the work of utilizing Monte 
Carlo techniques for quantifying uncertainty in public health risk assessments.  
According to their work: 
“The first step in the Monte Carlo simulation is to determine (continuous or 
discrete) probability distribution functions (PDFs) to describe each of the variable 
in the uncertainty analysis.  In the simulation, each of many input variables can 
become a random variable with known or estimated PDF [or equivalently, a 
cumulative distribution function (CDF)].  Within this framework, a variable takes 
on a range of values with a known probability. Some distributions, for instance, 
are based on normal human variability and they come into play in the uncertainty 
analysis because we are uncertain who the person is that will actually be 
following the scenario”(Thompson, Burmaster, Crouch, 1992, p54). 
 
In this model, two separate PDFs are developed and applied for obtaining quetelet index 
values (i.e., children ages 5-10 years of age and adolescents 11-17 years of age).  The 
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quetelet index PDF utilizes a histogram of probabilities from the Bogalusa Heart Study 
(Table 4). 
Table 4 BMI Probability Distribution (ages 5-10) 
 
BMI Range Frequency 
of 
Occurrence 
Range Probability 
for Range 
Probability 
per Percentile 
0 =< x < 25 904 25 0.2512 0.0100 
25 =< x < 50 817 25 0.2270 0.0091 
50 =< x < 75 798 25 0.2217 0.0089 
75 =< x < 85 340 10 0.0945 0.0094 
85 =< x < 95 384 10 0.1067 0.0107 
95 =< x < 97 100 2 0.0278 0.0139 
97 =< x < 100 256 3 0.0711 0.0237 
 
Similar a histogram is created for adolescents ages 11-17 using probabilities established 
from the Bogalusa Heart Study. 
Table 5 BMI Probability Distribution (ages 11-17) 
 
BMI Range Frequency 
of 
Occurrence 
Range Probability 
for Range 
Probability 
per Percentile 
0 =< x < 25 1189 25 0.2135 0.0085 
25 =< x < 50 1122 25 0.2015 0.0081 
50 =< x < 75 1249 25 0.2243 0.0090 
75 =< x < 85 611 10 0.1097 0.0110 
85 =< x < 95 763 10 0.1370 0.0137 
95 =< x < 97 210 2 0.0377 0.0189 
97 =< x < 100 424 3 0.0761 0.0254 
 
Cardiovascular risk factors of childhood and adolescent overweight 
 
The cardiovascular risk factor model, will direct each trial or randomly generated 
individual through a second series of equations.  The equations determine the individual’s 
probability for being “at risk” of cardiovascular disease based on a particular risk factor.   
Using regression analysis, polynomial equations are derived to explain the 
relationship between quetelet index and the probability of being at risk for cardiovascular 
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disease due to a particular risk factor.  Cardiovascular risk factors in scope for this 
analysis include: 
• Total Cholesterol > 200 mg/dL 
• Triglycerides > 130 mg/dL 
• Low-Density Lipoprotein Cholesterol > 130 mg/dL 
• High-Density Lipoprotein Cholesterol < 35 mg/dL 
• Fasting Insulin > 95th Percentile 
• Systolic Blood Pressure > 95th Percentile 
• Diastolic Blood Pressure > 95th Percentile 
 
Utilizing probabilities from Freedman et al. polynomial equations are developed 
to represent the relationships between BMI and cardiovascular risk factor probabilities. 
Figures IV-1 and IV-2 show the relationship of quetelet index (or BMI) in children and 
adolescents to the probability of total cholesterol exceeding 200 mg/dL. 
Figure IV-1 Relationship of quetelet index in children ages 5-10 to probability of total cholesterol > 
200 mg/dL 
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Figure IV-2 Relationship of quetelet index in children ages 11-17 to probability of total cholesterol > 
200 mg/dL 
 
 
 
Likewise, Equations 3 through 16 show the relationships for each cardiovascular risk 
factor by age group. .  Graphs for each equation are also available in Appendix E. 
Equation 3 - Probability of at risk for total cholesterol as a function of quetelet index (ages 5-10) 
 
y = 0.0000300x2 - 0.0020978x + 0.1188745 
 
x = probability of total cholesterol > 200 mg/dL; y = quetelet index 
 
Equation 4 - Probability of at risk for total cholesterol as a function of quetelet index (ages 11-17) 
 
y = 0.0000286x2 - 0.0020420x + 0.0857550 
 
x = probability of total cholesterol > 200 mg/dL; y = quetelet index 
 
Equation 5 - Probability of at risk for triglycerides as a function of quetelet index (ages 5-10) 
 
y = 0.0000401x2 - 0.0030472x + 0.0633072 
 
x = probability of Triglycerides > 130 mg/dL; y = quetelet index 
 
Equation 6 - Probability of at risk for triglycerides as a function of quetelet index (ages 11-17) 
 
y = 0.0000677x2 - 0.0053929x + 0.1072561 
 
x = probability of Triglycerides > 130 mg/dL; y = quetelet index 
           Page 25  
 
Equation 7 - Probability of at risk for Low-Density Lipoprotein Cholesterol as a function of quetelet 
index (ages 5-10) 
 
y = 0.0000315x2 - 0.0023502x + 0.1106534 
 
x = probability of Low-Density Lipoprotein Cholesterol > 130 mg/dL; y = quetelet index 
 
Equation 8 - Probability of at risk for Low-Density Lipoprotein Cholesterol as a function of quetelet 
index (ages 11-17) 
 
y = 0.0000335x2 - 0.0022955x + 0.0687305 
 
x = probability of Low-Density Lipoprotein Cholesterol > 130 mg/dL; y = quetelet index 
 
Equation 9 - Probability of at risk for High-Density Lipoprotein Cholesterol as a function of quetelet 
index (ages 5-10) 
 
y = 0.0000283x2 - 0.0024594x + 0.0859913 
 
x = probability of High-Density Lipoprotein Cholesterol < 35 mg/dL; y = quetelet index 
 
Equation 10 - Probability of at risk for High-Density Lipoprotein Cholesterol as a function of 
quetelet index (ages 11-17) 
 
y = 0.0000187x2 - 0.0007838x + 0.0752449 
 
x = probability of High-Density Lipoprotein Cholesterol < 35 mg/dL; y = quetelet index 
 
Equation 11 - Probability of at risk for Fasting Insulin as a function of quetelet index (ages 5-10) 
 
y = 0.0000582x2 - 0.0050417x + 0.0931682 
 
x = probability of Fasting Insulin > 95th Percentile; y = quetelet index 
 
Equation 12 - Probability of at risk for Fasting Insulin as a function of quetelet index (ages 11-17) 
 
y = 0.0000548x2 - 0.0045987x + 0.0760686 
 
x = probability of Fasting Insulin > 95th Percentile; y = quetelet index 
 
Equation 13 - Probability of at risk for Systolic Blood Pressure as a function of quetelet index (ages 
5-10) 
 
y = 0.0000435x2 - 0.0033672x + 0.0661171 
 
x = probability of Systolic Blood Pressure > 95th Percentile; y = quetelet index 
 
Equation 14 - Probability of at risk for Systolic Blood Pressure as a function of quetelet index (ages 
11-17) 
 
y = 0.0000042x2 + 0.0001590x + 0.0217240 
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x = probability of Systolic Blood Pressure > 95th Percentile; y = quetelet index 
 
Equation 15 - Probability of at risk for Diastolic Blood Pressure as a function of quetelet index (ages 
5-10) 
 
y = 0.0000183x2 - 0.0009286x + 0.0290296 
 
x = probability of Diastolic Blood Pressure > 95th Percentile; y = quetelet index 
 
Equation 16 - Probability of at risk for Diastolic Blood Pressure as a function of quetelet index (ages 
11-17) 
 
y = 0.0000037x2 - 0.0002198x + 0.0460476 
 
x = probability of Diastolic Blood Pressure > 95th Percentile; y = quetelet index 
 
High levels of insulin, systolic blood pressure and diastolic blood pressure were 
defined as those with greater than the 95th percentile for race, sex and age specific 
national standards. 
Model outputs 
 
Now that the model inputs are defined, Figures IV-3 and IV-4 provides an 
overview for the model architecture.  
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Figure IV-3 Cardiovascular Risk Factor Model (age 5-10) 
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Figure IV-4 Cardiovascular Risk Factor Model (age 11-17) 
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Once the risk factor probabilities are established for an individual based on 
quetelet index, a uniform distribution is utilized as a comparison constant.  In other 
words, say the probability for an individual being “at risk” due to total cholesterol is 0.25.  
A uniform distribution from 0.00 to 1.00 will randomly select a comparison constant.  If 
the comparison constant is .36, then the individual in not “at risk” for total cholesterol 
(i.e., .36 > .25).  If, however, the comparison constant were .19 the individual would be at 
risk for total cholesterol (i.e., .19 < .25). 
Two additional outputs of the model include: 
 
• Proportion of children and adolescents who are “At Risk for Overweight” but 
not “Overweight”.  Children and adolescents with a quetelet index greater 
than 85% but less than 95% (see Appendix A) are defined as “At Risk for 
Overweight” but not “Overweight”. 
 
• Proportion of children and adolescents who are “Overweight”.  Children and 
adolescents with a quetelet index greater than 95% (see Appendix A) are 
defined as “Overweight”. 
 
V. Discussion 
 
Simulation results for adolescents 5 to 10 years of age.   
 
The results from the first simulation model (Figure IV-3) for children ages 5 to 10 
are provided in Tables 6 through 9. Total number of occurrences and percentages are 
shown for all trials (Table 6), children with BMI < 85th percentile (Table 7), children with 
BMI between the 85th and 95th percentiles (Table 8), and children with BMI > 95th 
percentile (Table 9).  
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Table 6 Simulation results for all children ages 5 to 10 years 
 
Simulation results for all children ages 5 to 10 years 
  Yes No Total Percent 
Children "at risk for overweight" but who are not "overweight" 624 4376 5000 12.48% 
Children who are "overweight" 383 4617 5000 7.66% 
Total Cholesterol > 200 mg/dL? 645 4355 5000 12.90% 
Triglycerides > 130 mg/dL? 276 4724 5000 5.52% 
Low-Density Lipoprotein Cholesterol > 130 mg/dL? 540 4460 5000 10.80% 
High-Density Lipoprotein Cholesterol < 35 mg/dL? 322 4678 5000 6.44% 
Fasting Insulin > 95th Percentile? 244 4756 5000 4.88% 
Systolic Blood Pressure > 95th Percentile? 259 4741 5000 5.18% 
Diastolic Blood Pressure > 95th Percentile? 212 4788 5000 4.24% 
 
Table 7 Simulation results for healthy weight (quetelet index < 85th) children ages 5 to 10 years 
 
Simulation results for healthy weight (quetelet index < 85th) children ages 5 to 10 
years 
  Yes No Total Percent 
Total Cholesterol > 200 mg/dL? 455 3538 3993 11.39% 
Triglycerides > 130 mg/dL? 155 3838 3993 3.88% 
Low-Density Lipoprotein Cholesterol > 130 mg/dL? 367 3626 3993 9.19% 
High-Density Lipoprotein Cholesterol < 35 mg/dL? 221 3772 3993 5.53% 
Fasting Insulin > 95th Percentile? 114 3879 3993 2.85% 
Systolic Blood Pressure > 95th Percentile? 106 3887 3993 2.65% 
Diastolic Blood Pressure > 95th Percentile? 106 3887 3993 2.65% 
 
Table 8 Simulation results for "At risk for overweight" but not "Overweight" (85th < quetelet index 
< 95th) children ages 5 to 10 years 
 
Simulation results for "At risk for overweight" but not "Overweight" (85th < 
quetelet index < 95th) children ages 5 to 10 years 
  Yes No Total Percent 
Total Cholesterol > 200 mg/dL? 114 510 624 18.27% 
Triglycerides > 130 mg/dL? 66 558 624 10.58% 
Low-Density Lipoprotein Cholesterol > 130 mg/dL? 100 524 624 16.03% 
High-Density Lipoprotein Cholesterol < 35 mg/dL? 48 576 624 7.69% 
Fasting Insulin > 95th Percentile? 72 552 624 11.54% 
Systolic Blood Pressure > 95th Percentile? 91 533 624 14.58% 
Diastolic Blood Pressure > 95th Percentile? 62 562 624 9.94% 
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Table 9 Simulation results for "Overweight" (quetelet index > 95th) children ages 5 to 10 years 
 
Simulation results for "Overweight" (quetelet index > 95th) children ages 5 to 10 
years 
  Yes No Total Percent 
Total Cholesterol > 200 mg/dL? 76 307 383 19.84% 
Triglycerides > 130 mg/dL? 55 328 383 14.36% 
Low-Density Lipoprotein Cholesterol > 130 mg/dL? 73 310 383 19.06% 
High-Density Lipoprotein Cholesterol < 35 mg/dL? 53 330 383 13.84% 
Fasting Insulin > 95th Percentile? 58 325 383 15.14% 
Systolic Blood Pressure > 95th Percentile? 62 321 383 16.19% 
Diastolic Blood Pressure > 95th Percentile? 44 339 383 11.49% 
 
A comparison of Tables 6 through 9, concludes that the percentage of children “at 
risk” for various cardiovascular risk factors increased with each increasing level of 
severity in weight status.  What’s more, a status of “healthy weight” showed significant 
reduction in occurrence of cardiovascular risk factors.   
Tables 10 and 11 provide a summary of the results from the simulation model and 
the Bogalusa Heart Study.  A comparison of Tables 16 and 17 provides an example of the 
level of variation experienced in computer simulation. 
Table 10 Simulation results for children ages 5 to 10 years 
 
Simulation results for children ages 5 to 10 years 
  
All 
BMI BMI<85th 85th<BMI<95th BMI>95th 
Total Cholesterol > 200 mg/dL? 12.90% 11.39% 18.27% 19.84% 
Triglycerides > 130 mg/dL? 5.52% 3.88% 10.58% 14.36% 
Low-Density Lipoprotein Cholesterol > 130 mg/dL? 10.80% 9.19% 16.03% 19.06% 
High-Density Lipoprotein Cholesterol < 35 mg/dL? 6.44% 5.53% 7.69% 13.84% 
Fasting Insulin > 95th Percentile? 4.88% 2.85% 11.54% 15.14% 
Systolic Blood Pressure > 95th Percentile? 5.18% 2.65% 14.58% 16.19% 
Diastolic Blood Pressure > 95th Percentile? 4.24% 2.65% 9.94% 11.49% 
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Table 11 Bogalusa Heart Study results for children ages 5 to 10 years 
 
Bogalusa Heart Study results for children ages 5 to 10 years 
  
All 
BMI BMI<85th 85th<BMI<95th BMI>95th 
Total Cholesterol > 200 mg/dL? 12.01% 10.04% 18.00% 21.31% 
Triglycerides > 130 mg/dL? 5.25% 3.04% 10.00% 17.91% 
Low-Density Lipoprotein Cholesterol > 130 mg/dL? 10.66% 8.52% 18.00% 19.91% 
High-Density Lipoprotein Cholesterol < 35 mg/dL? 6.43% 5.16% 8.00% 14.91% 
Fasting Insulin > 95th Percentile? 4.53% 2.40% 4.00% 22.22% 
Systolic Blood Pressure > 95th Percentile? 5.06% 3.03% 7.00% 19.19% 
Diastolic Blood Pressure > 95th Percentile? 4.69% 3.39% 7.00% 12.60% 
 
Utilizing the results from Tables 6 through 9 several implications can be made 
that are relevant for addressing overweight in children and adolescents in the future.  The 
sensitivity analysis provided in Figures V-1 and V-2 show the risk factors that are most 
sensitive to weight status.  Particularly, Figure V-1 shows the sensitivity of risk factors by 
healthy weight status (BMI less than 85th percentile) and “at risk of overweight” status 
(BMI between 85th and 95th percentiles). 
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Figure V-1 Sensitivity analysis of risk factors by simulated percentage at risk (ages 5-10) 
 
Sensitivity analysis of risk factors (ages 5-10)
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First, the most sensitive risk factor appears to be systolic blood pressure (SBP).  
This is identified because of the steep slope of the SBP line.  Based on this finding, 
public health professionals may infer that interventions aimed at SBP levels in 
overweight children are most critical (because of the sensitivity to weight status).  
However, this assumption should be weighted against the significance that SBP has on 
specific outcomes such as cardiovascular disease. 
Second, risk for total cholesterol (TC) levels has the highest percentages for both 
“healthy weight” children as well as children with a weight status of “at risk for 
overweight”, but not “overweight”.  This may indicate the criticality for public health 
professionals to create interventions for addressing total cholesterol levels in children of 
all weight statuses.  Here again, this decision should be weighed against the significance 
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of total cholesterol on specific outcomes such as cardiovascular disease.  However, it is 
clear that Monte Carlo simulation in conjunction with tools such as sensitivity analysis 
provide the means for gaining insight into the relationships between cardiovascular risk 
factors and child and adolescent BMI. 
Next, a similar sensitivity analysis is performed to examine the sensitivity of risk 
factors by weight status for “at risk of overweight” (BMI between 85th and 95th 
percentiles) and “overweight” (BMI greater than 95th percentile) children. 
Figure V-2 Sensitivity analysis of risk factors by simulated percentage at risk (ages 5-10) 
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From this graph, it is interesting to note that high-density lipoprotein cholesterol (HDLP) 
has the smallest slope value in Figure V-1 but has the steepest slope in Figure V-2.  This 
may indicate a need for creating interventions aimed at aimed at improving HDLP levels 
in children who have a BMI greater than the 95th percentile.    
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Simulation results for adolescents 11 to 17 years of age.   
 
The results from the second simulation model (Figure IV-4) for adolescents ages 
11 to 17 are provided in Tables 12 through 15. Total number of occurrences and 
percentages are shown for all trials (Table 12), adolescents with BMI < 85th percentile 
(Table 13), adolescents with BMI between the 85th and 95th percentiles (Table 14), and 
adolescents with BMI > 95th percentile (Table 15).  
Table 12 Simulation results for all adolescents ages 11 to 17 years 
 
Simulation results for all adolescents ages 11 to 17 years 
  Yes No Total Percent 
Adolescents "at risk for overweight" but who are not 
"overweight" 772 4228 5000 15.44% 
Adolescents who are "overweight" 569 4431 5000 11.38% 
Total Cholesterol > 200 mg/dL? 463 4537 5000 9.26% 
Triglycerides > 130 mg/dL? 447 4553 5000 8.94% 
Low-Density Lipoprotein Cholesterol > 130 mg/dL? 403 4597 5000 8.06% 
High-Density Lipoprotein Cholesterol < 35 mg/dL? 548 4452 5000 10.96% 
Fasting Insulin > 95th Percentile? 241 4759 5000 4.82% 
Systolic Blood Pressure > 95th Percentile? 233 4767 5000 4.66% 
Diastolic Blood Pressure > 95th Percentile? 250 4750 5000 5.00% 
 
Table 13 Simulation results for healthy weight (quetelet index < 85th) adolescents ages 11 to 17 years 
 
Simulation results for healthy weight (quetelet index < 85th) adolescents ages 11 
to 17 years 
  Yes No Total Percent 
Total Cholesterol > 200 mg/dL? 260 3399 3659 7.11% 
Triglycerides > 130 mg/dL? 191 3468 3659 5.22% 
Low-Density Lipoprotein Cholesterol > 130 mg/dL? 199 3460 3659 5.44% 
High-Density Lipoprotein Cholesterol < 35 mg/dL? 334 3325 3659 9.13% 
Fasting Insulin > 95th Percentile? 64 3595 3659 1.75% 
Systolic Blood Pressure > 95th Percentile? 139 3520 3659 3.80% 
Diastolic Blood Pressure > 95th Percentile? 173 3486 3659 4.73% 
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Table 14 Simulation results for "At risk for overweight" but not "Overweight" (85th < quetelet 
index < 95th) adolescents ages 11 to 17 years 
 
Simulation results for "At risk for overweight" but not "Overweight" (85th < 
quetelet index < 95th) adolescents ages 11 to 17 years 
  Yes No Total Percent 
Total Cholesterol > 200 mg/dL? 101 671 772 13.08% 
Triglycerides > 130 mg/dL? 129 643 772 16.71% 
Low-Density Lipoprotein Cholesterol > 130 mg/dL? 110 662 772 14.25% 
High-Density Lipoprotein Cholesterol < 35 mg/dL? 123 649 772 15.93% 
Fasting Insulin > 95th Percentile? 78 694 772 10.10% 
Systolic Blood Pressure > 95th Percentile? 50 722 772 6.48% 
Diastolic Blood Pressure > 95th Percentile? 37 735 772 4.79% 
 
Table 15 Simulation results for "Overweight" (quetelet index > 95th) adolescents ages 11 to 17 years 
 
Simulation results for "Overweight" (quetelet index > 95th) adolescents ages 11 to 
17 years 
  Yes No Total Percent 
Total Cholesterol > 200 mg/dL? 102 467 569 17.93% 
Triglycerides > 130 mg/dL? 127 442 569 22.32% 
Low-Density Lipoprotein Cholesterol > 130 mg/dL? 94 475 569 16.52% 
High-Density Lipoprotein Cholesterol < 35 mg/dL? 91 478 569 15.99% 
Fasting Insulin > 95th Percentile? 99 470 569 17.40% 
Systolic Blood Pressure > 95th Percentile? 44 525 569 7.73% 
Diastolic Blood Pressure > 95th Percentile? 40 529 569 7.03% 
 
A comparison of Tables 12 through 15, concludes that the percentage of 
adolescents “at risk” for various cardiovascular risk factors increased with each 
increasing level of severity in weight status.  Again, a status of “healthy weight” showed 
significant reduction in occurrence of cardiovascular risk factors.   
Tables 16 and 17 provide a summary of the results from the simulation model and 
the Bogalusa Heart Study.  A comparison of Tables 16 and 17 provides an example of the 
level of variation experienced in computer simulation. 
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Table 16 Simulation results for adolescents ages 11 to 17 years 
 
Simulation results for adolescents ages 11 to 17 years 
  
All 
BMI BMI<85th 85th<BMI<95th BMI>95th 
Total Cholesterol > 200 mg/dL? 9.26% 7.11% 13.08% 17.93% 
Triglycerides > 130 mg/dL? 8.94% 5.22% 16.71% 22.32% 
Low-Density Lipoprotein Cholesterol > 130 mg/dL? 8.06% 5.44% 14.25% 16.52% 
High-Density Lipoprotein Cholesterol < 35 mg/dL? 10.96% 9.13% 15.93% 15.99% 
Fasting Insulin > 95th Percentile? 4.82% 1.75% 10.10% 17.40% 
Systolic Blood Pressure > 95th Percentile? 4.66% 3.80% 6.48% 7.73% 
Diastolic Blood Pressure > 95th Percentile? 5.00% 4.73% 4.79% 7.03% 
 
Table 17 Bogalusa Heart Study results for adolescents ages 11 to 17 years 
 
Bogalusa Heart Study results for adolescents ages 11 to 17 years 
  
All 
BMI BMI<85th 85th<BMI<95th BMI>95th 
Total Cholesterol > 200 mg/dL? 9.00% 6.74% 15.00% 16.68% 
Triglycerides > 130 mg/dL? 8.10% 4.45% 12.00% 27.36% 
Low-Density Lipoprotein Cholesterol > 130 mg/dL? 7.83% 5.33% 13.00% 18.02% 
High-Density Lipoprotein Cholesterol < 35 mg/dL? 10.78% 8.88% 14.00% 19.34% 
Fasting Insulin > 95th Percentile? 4.27% 1.75% 5.00% 20.03% 
Systolic Blood Pressure > 95th Percentile? 5.00% 4.03% 7.00% 9.01% 
Diastolic Blood Pressure > 95th Percentile? 4.92% 4.71% 4.00% 7.34% 
 
Figure V-3 provides a sensitivity analysis of risk factors by healthy weight status 
(BMI less than 85th percentile) and “at risk of overweight” status (BMI between 85th and 
95th percentiles) for ages 11-17. 
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Figure V-3 Sensitivity analysis of risk factors by simulated percentage at risk (ages 11-17) 
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From this graph, triglycerides had not only the steepest slope but also the highest 
percentage of at risk adolescents between the ages of 11 to 17 when moving from a status 
of “health weight” to “at risk for overweight” but not ‘overweight”.  Based on this 
finding, public health professionals may need to focus more attention on intervention for 
reducing triglyceride levels in adolescents between the ages of 11 to 17.  
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Figure V-4 Sensitivity analysis of risk factors by simulated percentage at risk (ages 11-17) 
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Based on the sensitivity analysis in Figure V-4, triglycerides, again, have the 
highest percentage of “at risk” 11 to 17 year olds.  It is also interesting to note that the 
percentage of adolescents at risk for High-Density Lipoprotein Cholesterol (HDLC) has 
almost no change when moving from children who are “at risk of overweight” but not 
“overweight’ to a status of “overweight”.  This may indicate an opportunity for public 
health professionals to focus resources on interventions that target other risk factors for 
children.  However, this decision should only be made after considering variables such as 
the weighted impact HDLC has on outcomes such as cardiovascular disease when 
compared to other risk factors. 
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Multiple risk factor analysis 
 
Utilizing the results from the previous section, a multiple risk factor analysis is 
performed to illustrate how Monte Carlo simulation can provide insight into co-existence 
of risk factors as a result of BMI.  Analysis is performed separately for children and 
adolescents. 
Total number of co-existing risk factors for children 5 to 10 years of age 
 
Graphs showing frequency by number of co-existing cardiovascular risk factors 
are presented separately for all children ages 5 to 10 (Figure V-5), children of “healthy 
weight” ages 5 to 10 (Figure V-6), children “at risk for overweight” ages 5 to 10 (Figure 
V-7), and “overweight” children ages 5 to 10 (Figure V-8).  It is important to note that 
each graph utilizes a different scale for the y-axis.  Additionally, each graph utilizes a 
different sample size making the percentage of children with multiple risk factors the 
most significant measure of comparison. 
Figure V-5 Total number of co-existing risk factors for children ages 5 to 10 (combined weight status 
n=5,000) 
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Figure V-6 Total number of co-existing risk factors for children ages 5 to 10 who are not “at risk for 
overweight” or “overweight” (n=3993) 
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Figure V-7 Total number of co-existing risk factors for children "at risk for overweight” but who are 
not “overweight” ages 5 to 10 (n=624) 
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Figure V-8 Total number of co-existing risk factors for children who are "overweight" ages 5 to 10 
(n=383) 
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After comparing Figures V-5 through V-8, the proportion of children with co-
existing risk factors increased with each increasing level of severity in weight status.  
What’s more, a status of “healthy weight” showed significant reduction in occurrence of 
cardiovascular risk factors.   
Total number of co-existing risk factors for children 11 to 17 years of age.   
 
Graphs showing frequency by number of co-existing cardiovascular risk factors 
are presented separately for all adolescents ages 11 to 17 (Figure V-9), adolescents of 
“healthy weight” ages 11 to 17 (Figure V-10), adolescents “at risk for overweight” ages 
11 to 17 (Figure V-11), and “overweight” adolescents ages 11 to 17 (Figure V-12).  It is 
important to note that each graph utilizes a different scale for the y-axis.  Additionally, 
each graph utilizes a different sample size making the percentage of children with 
multiple risk factors the most significant measure of comparison. 
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Figure V-9 Total number of co-existing risk factors for adolescents ages 11 to 17 (combined weight 
status n=5,000) 
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Figure V-10 Total number of coexisting risk factors for adolescents ages 11 to 17 who are not “at risk 
for overweight” or “overweight” (n=3659) 
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Figure V-11 Total number of coexisting risk factors for adolescents "at risk for overweight” but who 
are not “overweight” ages 11 to 17 (n=772) 
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Figure V-12 Total number of coexisting risk factors for adolescents who are "overweight" ages 11 to 
17 (n=569) 
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After comparing Figures 7-5 through 7-8, the proportion of adolescents with co-
existing risk factors increased with each increasing level of severity in weight status.  
Again, a status of “healthy weight” showed significant reduction in occurrence of 
cardiovascular risk factors. 
Changes in risk factors due to controlled BMI 
 
This next section examines how cardiovascular risk factors in children and 
adolescents may change with changes in BMI. 
A new model is now constructed assuming that child and adolescent BMI levels 
return to recommended standards as presented by the CDC growth charts released in May 
of 2000 (see Appendix A).  The new model is modified to predict child and adolescent 
BMI patterns utilizing a histogram of CDC recommended BMI levels.  The model 
assumes that all relationships between quetelet index and the probabilities of having a 
specific cardiovascular risk factor will remain as defined within the original model. 
Under the revised model (i.e., 2000 distribution), two new simulations are 
performed of 5,000 Monte Carlo trials.   
Results for children 5 to 10 years of age under the 2000 distribution model 
 
The first simulation is performed for children ages 5 to 10.  Totals of weight 
status and individual risk factors are presented separately for all children ages 5 to 10 
(Table 18), children of “healthy weight” ages 5 to 10 (Table 19), children “at risk for 
overweight” ages 5 to 10 (Table 20), and “overweight” children ages 5 to 10 (Table 
21). 
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Table 18 Simulation results for all children ages 5 to 10 years (2000 distribution model) 
 
Simulation results for all children ages 5 to 10 years 
  Yes No Total Percent 
Children "at risk for overweight" but who are not "overweight" 486 4514 5000 9.72% 
Children who are "overweight" 214 4786 5000 4.28% 
Total Cholesterol > 200 mg/dL? 615 4385 5000 12.30% 
Triglycerides > 130 mg/dL? 228 4772 5000 4.56% 
Low-Density Lipoprotein Cholesterol > 130 mg/dL? 512 4488 5000 10.24% 
High-Density Lipoprotein Cholesterol < 35 mg/dL? 312 4688 5000 6.24% 
Fasting Insulin > 95th Percentile? 190 4810 5000 3.80% 
Systolic Blood Pressure > 95th Percentile? 212 4788 5000 4.24% 
Diastolic Blood Pressure > 95th Percentile? 219 4781 5000 4.38% 
 
Table 19 Simulation results for healthy weight (quetelet index < 85th) children ages 5 to 10 years 
(2000 distribution model) 
 
Simulation results for healthy weight (quetelet index < 85th) children ages 5 to 10 
years 
  Yes No Total Percent 
Total Cholesterol > 200 mg/dL? 474 3826 4300 11.02% 
Triglycerides > 130 mg/dL? 140 4160 4300 3.26% 
Low-Density Lipoprotein Cholesterol > 130 mg/dL? 392 3908 4300 9.12% 
High-Density Lipoprotein Cholesterol < 35 mg/dL? 229 4071 4300 5.33% 
Fasting Insulin > 95th Percentile? 112 4188 4300 2.60% 
Systolic Blood Pressure > 95th Percentile? 125 4175 4300 2.91% 
Diastolic Blood Pressure > 95th Percentile? 152 4148 4300 3.53% 
 
Table 20 Simulation results for "At risk for overweight" but not "Overweight" (85th < quetelet 
index < 95th) children ages 5 to 10 years (2000 distribution model) 
 
Simulation results for "At risk for overweight" but not "Overweight" (85th < 
quetelet index < 95th) children ages 5 to 10 years 
  Yes No Total Percent 
Total Cholesterol > 200 mg/dL? 88 398 486 18.11% 
Triglycerides > 130 mg/dL? 54 432 486 11.11% 
Low-Density Lipoprotein Cholesterol > 130 mg/dL? 86 400 486 17.70% 
High-Density Lipoprotein Cholesterol < 35 mg/dL? 58 428 486 11.93% 
Fasting Insulin > 95th Percentile? 49 437 486 10.08% 
Systolic Blood Pressure > 95th Percentile? 56 430 486 11.52% 
Diastolic Blood Pressure > 95th Percentile? 39 447 486 8.02% 
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Table 21 Simulation results for "Overweight" (quetelet index > 95th) children ages 5 to 10 years 
(2000 distribution model) 
 
Simulation results for "Overweight" (quetelet index > 95th) children ages 5 to 10 
years 
  Yes No Total Percent 
Total Cholesterol > 200 mg/dL? 53 161 214 24.77% 
Triglycerides > 130 mg/dL? 34 180 214 15.89% 
Low-Density Lipoprotein Cholesterol > 130 mg/dL? 34 180 214 15.89% 
High-Density Lipoprotein Cholesterol < 35 mg/dL? 25 189 214 11.68% 
Fasting Insulin > 95th Percentile? 29 185 214 13.55% 
Systolic Blood Pressure > 95th Percentile? 31 183 214 14.49% 
Diastolic Blood Pressure > 95th Percentile? 28 186 214 13.08% 
 
As was expected, a comparison of Tables 18 through 21 conclude that the 
percentage of children “at risk” for various cardiovascular risk factors increased with 
each increasing level of severity in weight status.  Sensitivity for any particular risk factor 
may be assessed by comparing the degree of change between original and revised 
models.  Figures V-13 through V-15 show side-by-side comparisons to illustrate the 
impact of reduced BMI on weight status, total cholesterol and co-existence of three 
cardiovascular risk factors.  Graphs for each specific risk factor as well as greater 
breakdowns in evaluating the co-existence of risk factors for each age group are available 
in Appendix F.  
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Figure V-13 Simulation comparison- Children ages 5 to 10 by weight status 
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Figure V-14 Simulation comparison- Children ages 5 to 10 w/ total cholesterol > 200 mg/dL 
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Figure V-15 Simulation comparison- Children ages 5 to 10 w/ 3 out of 7 risk factors 
 
31.1%
35.1%
33.8%
27.3%
30.9%
41.8%
0
10
20
30
40
50
60
70
80
Observed Distribution 2000 Distribution
Children ages 5 to 10 w/ 3 out of 7 risk factors
healthy weight "at risk but not overweight" "overweight"
74
55
 
 
Results for adolescents 11 to 17 years of age under the 2000 distribution model 
 
The next simulation is performed for adolescents ages 11 to 17.  Totals of 
weight status and individual risk factors are presented separately for all adolescents 
ages 11 to 17 (Table 22), adolescents of “healthy weight” ages 11 to 17 (Table 23), 
adolescents “at risk for overweight” ages 11 to 17 (Table 24), and “overweight” 
adolescents ages 11 to 17 (Table 25). 
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Table 22 Simulation results for all children ages 11 to 17 years (2000 distribution model) 
 
Simulation results for all adolescents ages 11 to 17 years 
  Yes No Total Percent 
Adolescents "at risk for overweight" but who are not 
"overweight" 504 4496 5000 10.08% 
Children who are "overweight" 212 4788 5000 4.24% 
Total Cholesterol > 200 mg/dL? 371 4629 5000 7.42% 
Triglycerides > 130 mg/dL? 317 4683 5000 6.34% 
Low-Density Lipoprotein Cholesterol > 130 mg/dL? 348 4652 5000 6.96% 
High-Density Lipoprotein Cholesterol < 35 mg/dL? 525 4475 5000 10.50% 
Fasting Insulin > 95th Percentile? 194 4806 5000 3.88% 
Systolic Blood Pressure > 95th Percentile? 219 4781 5000 4.38% 
Diastolic Blood Pressure > 95th Percentile? 217 4783 5000 4.34% 
 
Table 23 Simulation results for healthy weight (quetelet index < 85th) children ages 11 to 17 years 
(2000 distribution model) 
 
Simulation results for healthy weight (quetelet index < 85th) adolescents ages 11 
to 17 years 
  Yes No Total Percent 
Total Cholesterol > 200 mg/dL? 288 3994 4282 6.73% 
Triglycerides > 130 mg/dL? 171 4111 4282 3.99% 
Low-Density Lipoprotein Cholesterol > 130 mg/dL? 231 4051 4282 5.39% 
High-Density Lipoprotein Cholesterol < 35 mg/dL? 399 3883 4282 9.32% 
Fasting Insulin > 95th Percentile? 91 4191 4282 2.13% 
Systolic Blood Pressure > 95th Percentile? 160 4122 4282 3.74% 
Diastolic Blood Pressure > 95th Percentile? 167 4115 4282 3.90% 
 
Table 24 Simulation results for "At risk for overweight" but not "Overweight" (85th < quetelet 
index < 95th) children ages 11 to 17 years (2000 distribution model) 
 
Simulation results for "At risk for overweight" but not "Overweight" (85th < 
quetelet index < 95th) adolescents ages 11 to 17 years 
  Yes No Total Percent 
Total Cholesterol > 200 mg/dL? 53 451 504 10.52% 
Triglycerides > 130 mg/dL? 106 398 504 21.03% 
Low-Density Lipoprotein Cholesterol > 130 mg/dL? 72 432 504 14.29% 
High-Density Lipoprotein Cholesterol < 35 mg/dL? 88 416 504 17.46% 
Fasting Insulin > 95th Percentile? 69 435 504 13.69% 
Systolic Blood Pressure > 95th Percentile? 32 472 504 6.35% 
Diastolic Blood Pressure > 95th Percentile? 31 473 504 6.15% 
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Table 25 Simulation results for "Overweight" (quetelet index > 95th) children ages 11 to 17 years 
(2000 distribution model) 
 
Simulation results for "Overweight" (quetelet index > 95th) adolescents ages 11 to 
17 years 
  Yes No Total Percent 
Total Cholesterol > 200 mg/dL? 30 184 214 14.02% 
Triglycerides > 130 mg/dL? 40 174 214 18.69% 
Low-Density Lipoprotein Cholesterol > 130 mg/dL? 45 169 214 21.03% 
High-Density Lipoprotein Cholesterol < 35 mg/dL? 38 176 214 17.76% 
Fasting Insulin > 95th Percentile? 34 180 214 15.89% 
Systolic Blood Pressure > 95th Percentile? 27 187 214 12.62% 
Diastolic Blood Pressure > 95th Percentile? 19 195 214 8.88% 
 
Similar to the previous analysis, a comparison of Tables 22 through 25 concludes 
that the percentage of adolescents “at risk” for various cardiovascular risk factors 
increased with each increasing level of severity in weight status.  Figures V-16 through 
V-18 show side-by-side comparisons to illustrate the impact of reduced BMI on weight 
status, total cholesterol and co-existence of three cardiovascular risk factors.  Graphs for 
each specific risk factor as well as greater breakdowns in evaluating the co-existence of 
risk factors for each age group are available in Appendix F.  
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Figure V-16 Simulation comparison- Children ages 11 to 17 by weight status 
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Figure V-17 Simulation comparison- Children ages 11 to 17 w/ total cholesterol > 200 mg/dL 
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Figure V-18 Simulation comparison- Children ages 11 to 17 w/ 3 out of 7 risk factors 
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Study limitations and future opportunities 
 
Although simulation is a valuable tool in strategy development, it does present a 
number of limitations.  First and foremost, all simulation models are restricted to the 
principles of “garbage in: garbage out”.  A model is only as good as the probabilities used 
in its design.  The model presented in this thesis was designed using probabilities from 
the Bogalusa Heart Study.  It is important to note that the population used in this study 
comes from a region of the U.S. that is more likely to be at risk for overweight.  The 
potential exists to improve model accuracy by combining data from other studies to 
create larger data sets and more accurate probabilities. 
The study population was limited to 43,000 (1/3 black, 2/3 white) schoolchildren 
between the ages of 5 and 17 years.  Analysis was restricted to individuals who properly 
fasted and who had recorded values for weight, height, total cholesterol and systolic 
           Page 54  
blood pressure.  The resulting sample was restricted to a sample size of 9,167 
schoolchildren between the ages of 5 and 17 years.   
Additional limitations include the following:   
Accuracy of BMI readings - BMI is a good tool for broad categorization of populations 
for statistical purposes.  That said, BMI does come with limitations.  Distortions to this 
index may be attributed to factors such as fitness level, muscle mass, bone structure, 
gender and ethnicity. 
 
Sampling error - The model is subject to limitations in population sample sizes and 
aggregation of data for ages 5-10 and 11-17 years.  Additionally, the revised simulation 
model presented in Chapter V utilizes the same polynomial equations for cardiovascular 
risk factors derived from the original probabilities obtained through the Bogalusa Heart 
Study.  This generalization may contribute to larger sampling error. 
 
Relationships between risk factors - The model treats each risk factor independently and 
does not account for the complexities of relationships that exist between risk factors.  It is 
outside the scope of this paper to explain all relationships that may exist between data 
points.   
 
Regression analysis - The model is limited by the generalizations of calculating trend 
lines and in using quetelet index ranges for each predicted cardiovascular risk factor. 
 
Trial size - Each Monte Carlo simulation is performed for five iterations of 1,000 trials.  
Therefore, each simulation is limited to a total of 5,000 trials.    This number of trials is 
assumed sufficient in achieving the Law of Large Numbers.  Additionally, each iteration 
utilizes a different algorithm for generating numbers and therefore achieves greater 
randomness. 
 
VI. Conclusion 
 
This thesis examines the use of Monte Carlo computer simulation as a tool for 
assisting organizations in identifying effective strategies for fighting childhood 
overweight. The goal of this thesis is to help organizations understand the benefits and 
limitations of computer simulation modeling in predicting cardiovascular risk factors 
among overweight children and adolescents.   
The Monte Carlo computer models presented in Chapter IV (Figures IV-3 and IV-
4) assisted in explaining the relationships that exist between BMI and cardiovascular risk 
factors in children and adolescents.  Additionally, a sensitivity analysis was utilized to 
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determine the risk factors most sensitive to weight status.  Utilizing this information 
public health professionals can better make decisions regarding what interventions should 
receive attention, funding and resources.   
A multiple risk factor analysis also was performed to illustrate how changes in 
BMI impact changes in co-existing risk factors.  Utilizing this methodology public health 
professionals can quantify the degree by which changes in BMI impact probabilities for 
co-existing risk factors.   
A “what-if” scenario analysis compared how percentages of children and 
adolescents with cardiovascular risk factors may change if BMI levels were to return to 
2000 CDC standards (see Appendix A).  Public health professionals may find this 
analysis helpful when leveraging data produced through pilot programs.  Through pilot 
programs, health professionals may create their own probabilities and customized 
algorithms for predicting future events.  The application of Monte Carlo simulation is not 
limited to any specific public health problem and/or intervention.  Any event that evolves 
dynamically over time (e.g., disease, injury or behavior) can be assessed as long as data is 
available for defining a probability distribution.  This creates an almost unlimited number 
of opportunities for applying simulation to public health (e.g. predicting the occurrence of 
global pandemics, response times to terrorist attacks or spread of HIV/AIDS). 
According to Haddix, Teutsch and Corso (2003) Monte Carlo modeling can also 
be used for “extrapolating costs and health effects beyond the time horizon of a single 
clinical study.  These models can also provide quantitative insight into the relative 
importance of different components of the screening process and investigate how cost-
effectiveness ratios will change if values of key parameters are changed (Haddix, 
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Teutsch, Corso, 2003, p124).  It may be beneficial for future researchers to build financial 
and resource variables directly into the model for enhanced decision-making ability.  
Additionally, future research may assist in expanding the proposed model to 
include other variables such as caloric burn and/or caloric intake.  Likewise, the model 
may be subdivided to achieve greater granularity by age, sex, race and ethnicity.  There 
really is no limit in refining the model.  The more detailed the model the more accurate 
the results.     
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VIII. Appendix A – CDC growth charts: BMI-for-age percentiles 
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IX. Appendix B – Prevalence of overweight in children and adolescents 1999-2004 
 
 
 
 
Source: Ogden, C. L., Carroll, M.D., Curtin, L.R., McDowell M.A., Tabak, C.J., Flegal K.M. (2006). 
Prevalence of Overweight and Obesity in the United States, 1999-2004. Journal American Medical 
Association (JAMA), 295, 1549-1555 
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X. Appendix C – Overweight children & adolescents 1963–65 through 1999–2002 
 
 
 
Source: National Center for Health Statistics. Health, United States, 2004 with Chartbook on Trends in 
the Health of Americans.  Hyattsville, Maryland: 2004. 
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XI. Appendix D – Computer Simulation Theoretical Example 
 
To explore the concept of simulation consider a theoretical example where an 
individual suffers from frequent headaches.  Suppose headaches are classified into 
categories of weak, medium, bad or pounding.  Table D.1 lists all possible headache 
outcomes.  The corresponding probabilities indicate the likelihood of the individual’s 
status escalating to a given severity level within a 24 hour period. 
Table D.1 Simulation example - sample probabilities 
 
Severity Level Outcomes Probability 
1 no headache 0.70 
2 weak headache 0.12 
3 medium headache 0.09 
4 bad headache 0.06 
5 pounding headache 0.03 
 
 The above probabilities are helpful.  However, headache outcome 
probabilities are more useful when defined using conditional probabilities.  For 
example, assume that headache severity is related to the quality of lunch consumed 
that day (e.g., an individual has a higher probability of getting a headache given the 
individual ate a low quality lunch). 
The first step is to develop a distribution of the conditional variable.  The 
following table provides definitions for quality of lunch consumed in a 24-hour 
period. 
Table D.2 Simulation example - initial lunch quality levels 
 
Quality Level Category Probability 
1 skipped lunch 0.05 
2 poor lunch 0.20 
3 fair lunch 0.35 
4 good lunch 0.30 
5 great lunch 0.10 
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Utilizing Bayes Law, five new probability distributions are identified within the next five 
tables.   
 
Table D.3 Probabilities by headache severity given individual skipped lunch 
 
Severity Level Outcomes Probability 
1 no headache 0.62 
2 weak headache 0.14 
3 medium headache 0.11 
4 bad headache 0.08 
5 pounding headache 0.05 
 
Table D.4 Probabilities by headache severity given individual ate a poor quality lunch 
 
Severity Level Outcomes Probability 
1 no headache 0.66 
2 weak headache 0.13 
3 medium headache 0.10 
4 bad headache 0.07 
5 pounding headache 0.04 
 
Table D.5 Probabilities by headache severity given individual ate a fair quality lunch 
 
Severity Level Outcomes Probability 
1 no headache 0.70 
2 weak headache 0.12 
3 medium headache 0.09 
4 bad headache 0.06 
5 pounding headache 0.03 
 
Table D.6 Probabilities by headache severity given individual ate a good quality lunch 
 
Severity Level Outcomes Probability 
1 no headache 0.74 
2 weak headache 0.11 
3 medium headache 0.08 
4 bad headache 0.05 
5 pounding headache 0.02 
 
Table D.7 Probabilities by headache severity given individual ate a lunch of great quality 
 
Severity Level Outcomes Probability 
1 no headache 0.78 
2 weak headache 0.10 
3 medium headache 0.07 
4 bad headache 0.04 
5 pounding headache 0.01 
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Utilizing the above probabilities a model is constructed as shown below. 
Figure D.1 Simulation model of headache severity 
 
 
 
Utilizing a random number generator, a simulation of 1,000 Monte Carlo trials 
is performed.  The resulting probabilities by headache severity are defined below.  
Figure D.2 Relative frequency diagram of headache severity 
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Now that the current situation is modeled, assume an intervention is 
implemented that improves the probability distribution for quality of lunch consumed.  
The question is now: What is the expected outcome by headache severity given recent 
changes in quality of lunch consumed?  For this case, a revised probability 
distribution for quality of lunch consumed is utilized as follows:  
Table D.8 Simulation example - revised lunch quality levels 
 
Quality Level Category Probability 
1 skipped lunch 0.00 
2 poor lunch 0.05 
3 fair lunch 0.20 
4 good lunch 0.35 
5 great lunch 0.40 
 
 
The only modification required in the existing model is a change for 
probabilities of lunch quality.  The simulation is run again utilizing 1,000 Monte 
Carlo trails.  The results are displayed in the following relative frequency diagram.   
Figure D.3 Relative frequency diagram for headache severity after intervention 
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The new distribution of headache severity has significantly shifted to the left, 
indicating a drop in headache severity level.  This may provide useful when 
comparing the outcomes of various interventions. 
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XII. Appendix E – Relationships between quetelet index and risk factor probability 
 
Figure XII-1 Relationship of quetelet index in children ages 5-10 to probability of total cholesterol > 
200 mg/dL 
 
 
 
Figure XII-2 Relationship of quetelet index in children ages 11-17 to probability of total cholesterol > 
200 mg/dL 
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Figure XII-3 Relationship of quetelet index in children ages 5-10 to probability of triglycerides > 130 
mg/dL 
 
 
 
Figure XII-4 Relationship of quetelet index in children ages 11-17 to probability of triglycerides > 
130 mg/dL 
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Figure XII-5 Relationship of quetelet index in children ages 5-10 to probability of low-density 
lipoprotein cholesterol > 130 mg/dL 
 
 
 
Figure XII-6 Relationship of quetelet index in children ages 11-17 to probability of low-density 
lipoprotein cholesterol > 130 mg/dL 
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Figure XII-7 Relationship of quetelet index in children ages 5-10 to probability of high-density 
lipoprotein cholesterol < 35 mg/dL 
 
 
 
Figure XII-8 Relationship of quetelet index in children ages 11-17 to probability of high-density 
lipoprotein cholesterol < 35 mg/dL 
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Figure XII-9 Relationship of quetelet index in children ages 5-10 to probability of fasting insulin > 
95th percentile 
 
 
 
Figure XII-10 Relationship of quetelet index in children ages 11-17 to probability of fasting insulin > 
95th percentile 
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Figure XII-11 Relationship of quetelet index in children Ages 5-10 to probability of systolic blood 
pressure > 95th percentile 
 
 
 
Figure XII-12 Relationship of quetelet index in children ages 11-17 to probability of systolic blood 
pressure > 95th percentile 
 
 
 
 
 
 
           Page 75  
Figure XII-13 Relationship of quetelet index in children ages 5-10 to probability of diastolic blood 
pressure > 95th percentile 
 
 
 
Figure XII-14 Relationship of quetelet index in children ages 11-17 to probability of diastolic blood 
pressure > 95th percentile 
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XIII. Appendix F – Model comparison by cardiovascular risk factor 
 
Figure XIII-1 Simulation comparison- Children ages 5 to 10 w/ total cholesterol > 200 mg/dL 
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Figure XIII-2 Simulation comparison- Children ages 5 to 10 w/ triglycerides > 130 mg/dL 
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Figure XIII-3 Simulation comparison- Children ages 5 to 10 w/ low-density lipoprotein cholesterol > 
130 mg/dL 
 
13.5%
18.5%
68%
6.6%
16.8%
76.6%
0
100
200
300
400
500
600
Observed Distribution 2000 Distribution
Children ages 5 to 10 w/ low-density lipoprotein 
cholesterol > 130 mg/dL
healthy weight "at risk but not overweight" "overweight"
540 512
 
 
Figure XIII-4 Simulation comparison- Children ages 5 to 10 w/ high-density lipoprotein cholesterol < 
35 mg/dL 
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Figure XIII-5 Simulation comparison- Children ages 5 to 10 w/ fasting insulin > 95th percentile 
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Figure XIII-6 Simulation comparison- Children ages 5 to 10 w/ systolic blood pressure > 95th 
percentile 
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Figure XIII-7 Simulation comparison- Children ages 5 to 10 w/ diastolic blood pressure > 95th 
percentile 
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Figure XIII-8 Simulation comparison- Children ages 5 to 10 w/ 0 out of 7 risk factors 
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Figure XIII-9 Simulation comparison- Children ages 5 to 10 w/ 1 out of 7 risk factors 
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Figure XIII-10 Simulation comparison- Children ages 5 to 10 w/ 2 out of 7 risk factors 
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Figure XIII-11 Simulation comparison- Children ages 5 to 10 w/ 3 out of 7 risk factors 
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Figure XIII-12 Simulation comparison- Children ages 5 to 10 w/ 4 out of 7 risk factors 
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Figure XIII-13 Simulation comparison- Children ages 5 to 10 w/ (5 or more) out of 7 risk factors 
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Figure XIII-14 Simulation comparison- Children ages 11 to 17 w/ total cholesterol > 200 mg/dL 
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Figure XIII-15 Simulation comparison- Children ages 11 to 17 w/ triglycerides > 130 mg/dL 
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Figure XIII-16 Simulation comparison- Children ages 11 to 17 w/ low-density lipoprotein cholesterol 
> 130 mg/dL 
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Figure XIII-17 Simulation comparison- Children ages 11 to 17 w/ high-density lipoprotein cholesterol 
< 35 mg/dL 
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Figure XIII-18 Simulation comparison- Children ages 11 to 17 w/ fasting insulin > 95th percentile 
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Figure XIII-19 Simulation comparison- Children ages 11 to 17 w/ systolic blood pressure > 95th 
percentile 
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Figure XIII-20 Simulation comparison- Children ages 11 to 17 w/ diastolic blood pressure > 95th 
percentile 
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Figure XIII-21 Simulation comparison- Children ages 11 to 17 w/ 0 out of 7 risk factors 
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Figure XIIII-22 Simulation comparison- Children ages 11 to 17 w/ 1 out of 7 risk factors 
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Figure XIIII-23 Simulation comparison- Children ages 11 to 17 w/ 2 out of 7 risk factors 
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Figure XIIII-24 Simulation comparison- Children ages 11 to 17 w/ 3 out of 7 risk factors 
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Figure XIIII-25 Simulation comparison- Children ages 11 to 17 w/ 4 out of 7 risk factors 
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Figure XIIII-26 Simulation comparison- Children ages 11 to 17 w/ (5 or more) out of 7 risk factors 
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